Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-023-37860-8
Download full text from publisher
References listed on IDEAS
- Qing Chai & Joseph W. Arndt & Min Dong & William H. Tepp & Eric A. Johnson & Edwin R. Chapman & Raymond C. Stevens, 2006. "Structural basis of cell surface receptor recognition by botulinum neurotoxin B," Nature, Nature, vol. 444(7122), pages 1096-1100, December.
- Liang Tao & Lisheng Peng & Ronnie P.-A. Berntsson & Sai Man Liu & SunHyun Park & Feifan Yu & Christopher Boone & Shilpa Palan & Matthew Beard & Pierre-Etienne Chabrier & Pål Stenmark & Johannes Krupp , 2017. "Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors," Nature Communications, Nature, vol. 8(1), pages 1-10, December.
- Roger M. Benoit & Daniel Frey & Manuel Hilbert & Josta T. Kevenaar & Mara M. Wieser & Christian U. Stirnimann & David McMillan & Tom Ceska & Florence Lebon & Rolf Jaussi & Michel O. Steinmetz & Gebhar, 2014. "Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A," Nature, Nature, vol. 505(7481), pages 108-111, January.
- Rongsheng Jin & Andreas Rummel & Thomas Binz & Axel T. Brunger, 2006. "Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity," Nature, Nature, vol. 444(7122), pages 1092-1095, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Atsushi Yamagata & Kaori Ito & Takehiro Suzuki & Naoshi Dohmae & Tohru Terada & Mikako Shirouzu, 2024. "Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Atsushi Yamagata & Kaori Ito & Takehiro Suzuki & Naoshi Dohmae & Tohru Terada & Mikako Shirouzu, 2024. "Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37860-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.